Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1/2 Double Blind, Randomized Controlled Study to Evaluate the Safety and Efficacy of RUT58-60 Lavage Following Abdominal Surgery as an Adjunctive Therapy to Prophylactic Systemic Antibiotics

Next Previous
Trial Profile

A Phase 1/2 Double Blind, Randomized Controlled Study to Evaluate the Safety and Efficacy of RUT58-60 Lavage Following Abdominal Surgery as an Adjunctive Therapy to Prophylactic Systemic Antibiotics

Status: Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 11 Aug 2015

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs RUT 58 60 (Primary)
  • Indications Bacterial infections; Postoperative infections
  • Focus Adverse reactions
  • Sponsors Ruthigen

Most Recent Events

  • 06 Aug 2015 Status changed from recruiting to discontinued, as reported by ClinicalTrials.gov.
  • 04 Nov 2014 New source identified and integrated (ClinicalTirals.gov: US National Institutes of Health - NCT02280395).
  • 08 Oct 2014 Completion of enrolment of 20 patients in phase I is planned for the fourth quarter of 2014, and completion of enrolment of another 130 patients for phase II is planned by the end of the first quarter of 2015, according to a Ruthigen media release.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top